Global Biosimilars Week, 3 - 7 November 2025
2025-11-03 - 2025-11-07
On behalf of the International Generic and Biosimilar Medicines Association (IGBA), the GBMA is pleased to officially announce that the 6th Annual Global Biosimilars Week social media awareness campaign will take place from November 3 to 7, 2025.
This year’s theme is Biosimilars: A Wise Investment for Global Health – better access to biosimilar medicines will help more people live healthier lives worldwide.
We warmly invite all stakeholders in Australia to show their support of biosimilars throughout the week by using the hashtags #GlobalBiosimilarsWeek and #GBW25.
To support participation, a social media toolkit is available for download with campaign logos, customisable image templates, sample posts and other resources. Please note that because this is an international resource, some of the messaging may need tailoring to ensure they are appropriate for the Australian market.

Global Webinar – Wed 5th November
As the world faces increasing health challenges, biosimilar medicines offer a promising solution to enhance accessibility, affordability, and sustainability of healthcare systems worldwide, which are all important pillars to meet the UN Sustainable Development Goals for Health by 2030

To learn more, visit the IGBA’s global site: Global Biosimilars Week 2025
Questions? Please reach out to the GBMA via our ‘Contact us’ page.

GBMA Summit - No patient left waiting: end the era of medicine shortages
2026-02-04 09:30 - 14:00 (Australia/Sydney) | Parliament House, Australia
Thank you to everyone who attended the recent GBMA Summit – No patient left waiting: ending the era of medicine shortages
Government, industry and healthcare leaders came together at the GBMA Summit to explore some of the contributors to medicine shortages and discuss how healthcare stakeholders can together chart a path toward sustainable access to medicines for Australians.
The program opened with key insights to set the context for the day, including global perspectives and keynote addresses from the Minister for Health, Disability and Ageing The Hon. Mark Butler MP and Shadow Minister for Health and Aged Care Senator the Hon. Anne Ruston, before moving through three focused sessions.

Session 1: Barriers, examining how Australia’s reimbursement settings can contribute to unintended disruptions;
Session 2: Opportunity and agility, exploring globally informed, action-oriented solutions for effective reporting and stronger system responsiveness; and
Session 3: Access and processes, identifying practical reforms to streamline regulation without compromising safety.

Confirmed speakers:

The Hon. Mark Butler MP, Minister for Health, Disability and Ageing
Senator the Hon. Anne Ruston, Shadow Minister for Health and Aged Care
Hon. Prof. Jane Halton AO PSM, Independent Chair, GBMA
Marnie Peterson, Chief Executive Officer, GBMA
Assoc. Prof. Tom Simpson, President, Adpha
Luke Escombe, Ambassador for Crohn’s and Colitis Australia
Hayley Tamborini, Chief Commercial Officer, Arrotex
Clint Holland, Country Head, Sandoz
Steve Graham, General Manger, Commercial (Business Development), DBG Health
Dr Stephen Jenkins, Director Government & Corporate Affairs APAC, Teva Pharma
Sue MacLeman, Chair and Non-Executive Director, Medicines Australia
Nick Henderson, First Assistant Secretary, Medicines Regulation Division, TGA
Elizabeth Cuming, Chief Executive Officer, NPSA
Anthony Tassone, Victoria Branch Vice President & National Councilor, The Pharmacy Guild of Australia
Chad Rieger, Head of Medical Affairs and Policy, Australia and New Zealand, Sandoz
Fleur Douy, Senior Regulatory Affairs Manager, Arrotex
Chris Campbell, General Manager Policy and Program Delivery, PSA
